Taken together, these data identified that the AURKB—PI3K/AKT axis is critical for ICC EMT and development, suggesting that AURKB and AKT can be used as curative targets to surmount the poor prognosis in ICC patients with high AURKB expression. The gene discussed is AURKB; the disease is intrahepatic cholangiocarcinoma.